RecruitingNot ApplicableNCT07095608

Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain


Sponsor

New York University

Enrollment

80 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a prospective study involving human participants. Pressure and stretch sensitivity measures between oral cancer patients and healthy subjects will be compared. Pain stimulation will be conducted on the site of the cancer in 40 oral cancer patients, and on the tongue in 40 healthy volunteers, using pressure and stretch sensitivity tests.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating the role of a specific protein called TRPV4 — found in cells called Schwann cells that surround nerve fibers — in causing pain in people with oral cancer (cancer of the mouth). Researchers will collect tissue samples during surgery to better understand how nerve pain in oral cancer works, which may help develop better pain treatments in the future. **You may be eligible if...** - You are 18 years or older - You are in good general health (for healthy volunteers) - OR you have been diagnosed with squamous cell carcinoma (a common type of oral cancer) that requires surgical removal, and the tumor is at least 1 cm in size **You may NOT be eligible if...** - You are a healthy volunteer who has pre-cancer or cancer of the mouth - You are pregnant or breastfeeding - You have had prior surgery, chemotherapy, or radiation for head and neck cancer (for cancer patients) - You have any condition that would put you at increased risk or prevent your full participation in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPressure and stretch sensitivity testing

We will measure pressure sensitivity by applying gradual pressure (50 kPa/s) at the site of testing using a digital pressure algometer. In healthy subjects, we will perform these measurements on the lateral tongue on the left and the right side. In cancer patients, we will first test on the unaffected contralateral matched site and then at the site of the cancer. We will define pressure sensitivity as the mean of three threshold measurements. For measuring stretch sensitivity, we will use a visual analog scale (VAS) recording of pain scores associated with tongue stretching. Participants will be asked to perform tongue range of motions (ROM): protrusion, elevation, right and left lateralization, and rate sensitivity score on the VAS scale after holding the tongue in position for five seconds. We will define stretch sensitivity as the sum of VAS scores for protrusion, elevation, right and left lateralization.


Locations(1)

NYU College of Dentistry

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07095608


Related Trials